- Previous Close
72.20 - Open
70.80 - Bid --
- Ask --
- Day's Range
66.80 - 72.10 - 52 Week Range
44.15 - 85.60 - Volume
7,697 - Avg. Volume
4,577 - Market Cap (intraday)
927.213M - Beta (5Y Monthly) 1.06
- PE Ratio (TTM)
220.00 - EPS (TTM)
0.31 - Earnings Date Mar 18, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
91.13
Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company's medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. It provides osteosynthesis products for the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names. The company serves the surgeons, hospitals, and medical centers, as well as group purchasing organizations. The company was incorporated in 1997 and is headquartered in Basel, Switzerland.
www.medartis.comRecent News: MED.SW
View MorePerformance Overview: MED.SW
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MED.SW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MED.SW
View MoreValuation Measures
Market Cap
927.22M
Enterprise Value
921.08M
Trailing P/E
220.00
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.00
Price/Book (mrq)
3.40
Enterprise Value/Revenue
4.18
Enterprise Value/EBITDA
31.62
Financial Highlights
Profitability and Income Statement
Profit Margin
1.57%
Return on Assets (ttm)
1.98%
Return on Equity (ttm)
1.35%
Revenue (ttm)
224.83M
Net Income Avi to Common (ttm)
3.53M
Diluted EPS (ttm)
0.31
Balance Sheet and Cash Flow
Total Cash (mrq)
138.69M
Total Debt/Equity (mrq)
44.96%
Levered Free Cash Flow (ttm)
12.73M